| Jangka wektu | Prediksi rega | kepungkur | Sajarah | Wawasan |
|---|---|---|---|---|
| sesuk | $0.3701 ▼ -0.71% | wingi | $0.3738 ▲ +0.30% | Sesuk GT Biopharma Inc. Common Stock (GTBP) persiyapan wis anchored kanggo $0.3727 lan target $0.3701 (-0.71%). Waca sing cedhak yaiku kekurangane; nonton $0.3839 / $0.3615 amarga volatilitas sing diwujudake saben dina babagan 3.65%. |
Sesuk GT Biopharma Inc. Common Stock (GTBP) persiyapan wis anchored kanggo $0.3727 lan target $0.3701 (-0.71%). Waca sing cedhak yaiku kekurangane; nonton $0.3839 / $0.3615 amarga volatilitas sing diwujudake saben dina babagan 3.65%. | ||||
| Minggu | $0.3645 ▼ -2.20% | Minggu kepungkur | $0.3761 ▲ +0.92% | Model 7 dina GT Biopharma Inc. Common Stock pindhah saka $0.3761 menyang $0.3645 (-2.20%). Iku menehi konteks momentum kekurangane kanggo saham iki, supaya break watara $0.3839 / $0.3615 prakara luwih saka siji obah. |
Model 7 dina GT Biopharma Inc. Common Stock pindhah saka $0.3761 menyang $0.3645 (-2.20%). Iku menehi konteks momentum kekurangane kanggo saham iki, supaya break watara $0.3839 / $0.3615 prakara luwih saka siji obah. | ||||
| wulan | $0.3552 ▼ -4.69% | Wulan kepungkur | $0.3800 ▲ +1.97% | Target 1 wulan GT Biopharma Inc. Common Stock yaiku $0.3552 (-4.69%), dibandhingake karo referensi langsung ing cedhak $0.3727. Cakrawala iki nyampur tekanan tren saiki karo momentum rega, likuiditas, lan risiko khusus perusahaan. |
Target 1 wulan GT Biopharma Inc. Common Stock yaiku $0.3552 (-4.69%), dibandhingake karo referensi langsung ing cedhak $0.3727. Cakrawala iki nyampur tekanan tren saiki karo momentum rega, likuiditas, lan risiko khusus perusahaan. | ||||
| taun | $0.3414 ▼ -8.41% | Taun kepungkur | $0.3859 ▲ +3.53% | Skenario 1 taun GT Biopharma Inc. Common Stock nuduhake $0.3414 (-8.41%). Kapercayan luwih murah tinimbang baris jangka pendek, mula dianggep minangka konteks siklus lan priksa maneh sawise nganyari data pasar utama. |
Skenario 1 taun GT Biopharma Inc. Common Stock nuduhake $0.3414 (-8.41%). Kapercayan luwih murah tinimbang baris jangka pendek, mula dianggep minangka konteks siklus lan priksa maneh sawise nganyari data pasar utama. | ||||
| 5 Taun | $0.3088 ▼ -17.14% | 5 Taun kepungkur | $0.3995 ▲ +7.20% | Tampilan 5 taun GT Biopharma Inc. Common Stock yaiku $0.3088 (-17.14%). Iki minangka skenario arah sing dibangun saka owahing arah lan volatilitas sing diwatesi, dudu dalan sing dijamin. |
Tampilan 5 taun GT Biopharma Inc. Common Stock yaiku $0.3088 (-17.14%). Iki minangka skenario arah sing dibangun saka owahing arah lan volatilitas sing diwatesi, dudu dalan sing dijamin. | ||||
| Indikator | Nilai | Sinyal |
|---|---|---|
| regane | $0.3727 | agêng |
| Ganti saben dina | +0.38% | Ndhuwur |
| Volatilitas Kab | 20.0% | agêng |
| kapercayan | 58% | Ngisor |
| Sumber Data | nasdaq-screener | agêng |
| saiki | $0.3727 | Ganti saben dina | +0.38% |
| Pasar Kab | $11.76M | Sumber | nasdaq-screener |
Gagasan sing gegandhengan kanggo navigasi internal, diklompokaké miturut persiyapan sisih ndhuwur sing luwih kuwat lan kurang lemah ing pasar sing padha.